Pan Du

University of Notre Dame — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index930citations55works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(9), SARS-CoV-2 and COVID-19 Research(7), Cancer Genomics and Diagnostics(7), Cell death mechanisms and regulation(6), Cancer Research and Treatments(6)

Publications55 total

Tumor-informed ctDNA for recurrence and survival prediction in HPV-independent head and neck squamous cell carcinoma.
Journal of Clinical Oncology·2025
PRRX1 is a key regulator in the phenotypic transition between human normal dermal and keloid fibroblasts
Journal of Dermatological Science·2025· 3 cited
Implicit Neural Differential Model for Spatiotemporal Dynamics
arXiv (Cornell University)·2025Open Access
Identification of nuclear factor YA6 genes in sorghum and characterization of their involvement in drought tolerance
Frontiers in Plant Science·2025· 1 citedOpen Access
URINE TUMOR DNA ANALYSIS IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS TREATED WITH DURVALUMAB CONTAINING REGIMENS IN THE HCRN GU16-243: ADAPT-BLADDER TRIAL
Urologic Oncology Seminars and Original Investigations·2025
Implicit Neural Differential Model for Spatiotemporal Dynamics
SSRN Electronic Journal·2025· 3 citedOpen Access
Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer
The Journal of Liquid Biopsy·2024· 12 citedOpen Access
77P Whole-exome mutation profiling of cfDNA from over 2000 samples in major cancer indications
Annals of Oncology·2024Open Access
Abstract PO4-01-04: Clinical significance of Circulating tumor DNA (ctDNA) analysis in predicting pathologic complete remission in HER2-positive Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Cancer Research·2024
Abstract PO5-14-05: Circulating tumor DNA fraction correlates with residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer patients
Cancer Research·2024· 1 cited
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine
Cell Discovery·2023· 12 citedOpen Access
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial
The Lancet Regional Health - Western Pacific·2023· 12 citedOpen Access
Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method
Antibody Therapeutics·2023· 3 citedOpen Access
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above
Expert Review of Vaccines·2022· 5 citedOpen Access
Heterologous CoronaVac plus Ad5-nCOV versus homologous CoronaVac vaccination among elderly: a phase 4, non-inferiority, randomized study
2022· 3 citedOpen Access
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
PLoS Medicine·2022· 44 citedOpen Access
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): a randomized, observer-blinded, placebo-controlled trial
2022· 7 citedOpen Access
Human Muse cells-derived neural precursor cells as the novel seed cells for the repair of spinal cord injury
Biochemical and Biophysical Research Communications·2021· 9 cited
Correction: A Virus-infected, Reprogrammed Somatic Cell–derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic Cancer
Clinical Cancer Research·2021· 17 cited
A Virus-Infected, Reprogrammed Somatic Cell–Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer
Clinical Cancer Research·2019· 31 cited
page 1 of 3Next →

Frequent Co-authors

Bingya Yang(10), Yaohe Wang(10), Chun Yao(8), Zichun Hua(7), Xiaoyu Xu(6), Hongqin Zhuang(6), Wei Cheng(6), Zi‐Chun Hua(5), Wenhui Jiang(5), Pengfei Jin(5), Hongxing Pan(5), Fengcai Zhu(5), Haiyang Luo(5), Jianxiang Chen(4), Xiling Guo(4), Yin Chen(4), Fengjuan Shi(4), Jingxian Liu(4), Shuangshuang Lu(4), Chengyuan Mao(4)